CEO Chris Paquette Named PM360 Vanguard Award Finalist

PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, recently named DeepIntent CEO, Chris Paquette as a Trailblazer Vanguard Award finalist. 

Chris Paquette is Chief Executive Officer of DeepIntent, a marketing technology company he co-founded on the principle that digital media can influence positive health outcomes. MarketMatch™, the company’s healthcare technology platform, currently supports 20 major pharmaceutical companies and dozens of media agencies to advertise more than 200 healthcare brands. 

Since 2009, the PM360 Trailblazer awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts.

The Vanguard Award honors a pioneer who developed a new service, strategy, product, or technology that greatly impacted the industry. 

“This year’s finalists were pioneers in very different fields, but all of their work proved crucial in helping our industry to reach new heights,” says Anna Stashower, CEO and Publisher of PM360. “From developing a healthcare-specific programmatic platform to implementing a custom-built, robotic, automated drug discovery process to redefining website design by proving accuracy and empathy can coexist in medical content, their work is helping to better educate and treat patients in need.”

Finalists are acknowledged and winners will be announced during a special virtual celebration on Thursday, October 1, 2020 at 6 pm EST.

Learn more about DeepIntent’s Leadership Team here

More News

Connected TV works ‘harder and smarter’ for the ad dollar, new analysis finds
As more and more people flock to streaming channels over traditional TV, pharma ad dollars are following them. In this article for Fierce Pharma,...
Read More
Hands typing on laptop with a line graph on screen
Tapping new tech helps marketers matchmake rare disease drugs for elusive patients
Treating rare diseases is challenging enough, so you can imagine how difficult it is to reach the right healthcare audiences with info about specialty...
Read More
2022 image
Pharma marketing 2022: More digital shifts for reps, ads and drug launches, plus reputation and the metaverse
What trends can healthcare marketers expect in 2022? In this article for Endpoints News, CEO Chris Paquette discusses how pharma brands will be increasing...
Read More